Stem cell · Cost guide
What stem cell therapy
actually costs.
All-in pricing across six therapy types, compared with Korea, Japan, US and Mexico. No hidden booster doses. Itemized written quotes within 5 business days.
All-in cost comparison
China vs Korea, Japan, US, Mexico.
China
South Korea
Japan
USA
Mexico
Autologous bone-marrow MSC
$8,400–$18,000
$20,000–$35,000
$25,000–$45,000
$30,000–$60,000
$15,000–$25,000
Autologous adipose MSC
$10,000–$22,000
$22,000–$40,000
$28,000–$50,000
$35,000–$70,000
$15,000–$28,000
Allogeneic umbilical cord MSC
$10,000–$28,000
$25,000–$45,000
$30,000–$50,000
$35,000–$80,000
$18,000–$30,000
Exosome therapy course
$6,000–$15,000
$10,000–$22,000
$12,000–$25,000
$15,000–$35,000
$8,000–$18,000
NK-cell immunotherapy course
$15,000–$35,000
$30,000–$60,000
$35,000–$70,000
$50,000–$120,000
$25,000–$45,000
CAR-T therapy
$60,000–$140,000
$200,000–$350,000
$250,000–$400,000
$400,000–$500,000+
n/a
Sources: NMPA-licensed Chinese partner hospital itemized quotes 2024–2025; ISSCR private clinic survey 2023; published Korean / Japanese / US private cellular therapy pricing 2024. All-in pricing includes procedure + hospitalization + accommodation + coordination, excludes international airfare.
FAQ
Cost questions, answered.
- How much does stem cell therapy cost in China?
- All-in pricing including coordinator, accommodation and 14-day on-site stay: autologous MSC $8,400–$24,000; allogeneic umbilical cord MSC $10,000–$28,000; exosome therapy $6,000–$15,000; NK-cell immunotherapy $15,000–$35,000; CAR-T cellular therapy $60,000–$140,000. Pricing varies by hospital, cell count, dose protocol, and condition complexity. Always request itemized quotes from 2 partner hospitals before booking.
- What's included in the all-in price?
- Standard all-in package: pre-treatment medical workup; cell harvest (autologous) or matching (allogeneic); GMP-grade cell processing and quality control; physician consultations and infusion; hospitalization (3–7 days); 14-day on-site recovery accommodation; English-speaking coordinator throughout; 12-month telehealth follow-up; bilingual medical records. Excluded: international airfare, M-visa application fees, optional add-on diagnostics (full-body MRI, NGS, etc.).
- Why is stem cell therapy so much cheaper in China than the US?
- Three reasons: (1) facility cost — Chinese GMP-grade cellular labs operate at materially lower overhead than US private clinics; (2) physician cost — Chinese senior cellular therapy physicians command 30–50% lower fees than US peers; (3) regulation — NMPA approves protocols at Class A hospitals; the US restricts most autologous MSC outside narrow trials, pushing US patients to unregulated overseas markets at premium pricing. China's regulated market with high volume drives natural cost compression.
- Are there add-ons or hidden fees?
- At top NMPA-licensed Class A facilities, no — all-in quotes cover the standard protocol. Optional add-ons: extended hospitalization beyond 7 days (~$200–$500/day); additional cell doses (~$2,000–$5,000 per dose); add-on diagnostics (full-body MRI, NGS panel, advanced imaging); private nursing or family accommodation upgrades. Be wary of any clinic that quotes a low headline price then adds repeated 'booster' doses — at NMPA-licensed facilities the protocol is defined upfront.
- Does insurance cover stem cell therapy?
- Generally no for elective stem cell tourism. US Medicare and most domestic plans do not cover overseas elective treatment. Some global insurers (Cigna Global Plus, Bupa Global) may cover NMPA-approved indications (e.g. Ruibosheng for GVHD) at accredited Chinese hospitals — confirm in writing before booking. For non-approved indications, expect out-of-pocket payment.
- How does Chinese pricing compare to other stem cell tourism destinations?
- Indicative all-in autologous MSC pricing: China $8,400–$24,000; South Korea $20,000–$45,000 (premium tier); Japan $25,000–$50,000; Mexico $15,000–$30,000 (less regulated); Panama / Cayman $25,000–$60,000 (less regulated). China combines regulation (NMPA-licensed GMP facilities) with low pricing — a combination unavailable in most markets. Quality and cost both favour China for serious candidates.
Itemized quote
in 5 business days.
Submit your records. We’ll return two written quotes from NMPA-licensed Class A partner hospitals — broken out by cell processing, treatment, hospitalization and follow-up.